The rationale behind its unique recommendation in ALL is that most leukemic lymphoid cells display an epigenetic silencing of the gene encoding the enzyme asparagine synthetase (ASNS), which catalyzes the adenosine 5′-triphosphate (ATP)–dependent conversion of aspartate and glutamine into asparagine and glutamate. This evidence concerns the gene ASNS and acute lymphoblastic leukemia.